Loading stock data…
Teleflex Incorporated (TFX)
$127.49-2.37 (-1.83%)
Market ClosedLast close Jun 29
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Teleflex Incorporated in the Healthcare sector is trading at $127.49 with a market capitalization of $5.7B. Wall Street consensus targets $145.89 (9 analysts), implying a +14.4% move over the next 12 months. The stock is currently 9% below its 52-week high of $139.67, remaining 6.6% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +14.4% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $548.26M↑ | -$401.87M↓ | $913.02M↑ | $780.89M↑ | $414.26M |
| Gross Profit | $307.43M↑ | -$151.41M↓ | $451.64M↑ | $431.08M↑ | $255.43M |
| Operating Income | $37.03M↑ | -$164.65M↓ | $112.65M↓ | $177.48M↑ | $77.22M |
| Net Income | -$8.15M↑ | -$714.33M↓ | -$408.89M↓ | $122.58M↑ | $95.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.69B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
2142.67
Beta
Defensive asset. Lower volatility than the S&P 500.
0.81
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.80%
ROE
Average efficiency. Growth may require heavy reinvestment.
-32.71%
Volume
Today's trading volume
286,112
Recent News
Do Options Traders Know Something About Teleflex Stock We Don't?
Investors need to pay close attention to TFX stock based on the movements in the options market lately.
Surgical Equipment & Consumables - Specialty Stocks Q1 Recap: Benchmarking Teleflex (NYSE:TFX)
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Teleflex (NYSE:TFX) and its peers.
Here's How Innovation Fuels Globus Medical's Growth Momentum
GMED is accelerating product launches, FDA clearances and R&D investment, reinforcing its strategy to expand spine and orthopedic workflows.
Teleflex Freesolve Data Underscores Cardiology Ambitions And Debt Refinancing Trade Off
Teleflex (NYSE:TFX) released four-year clinical data for its Freesolve Resorbable Magnesium Scaffold from the BIOMAG-I study. The follow-up results report continued safety and no new adverse cardiac events over the extended period. The data adds long-term evidence for the Freesolve scaffold in interventional cardiology. For investors tracking NYSE:TFX, this update sits within the core interventional cardiology segment, where durable clinical results can matter as much as product features...
Sector Update: Healthcare Stocks Rise Pre-Bell Tuesday
Healthcare stocks were rising pre-bell Tuesday, with the State Street Health Care Select Sector SPDR